Patient Safety and Extended Release/Long-Acting Opioids [CME}

Research output: Other contribution

Abstract

Discusses the FDA's Risk Evaluation and Mitigation Strategy (REMS) for extended-release and long-acting (ER/LA) opioid analgesics.

Original language	American English
State	Published - 2012

@misc{c2086b7f82694f5394ae481ef46ea35e,

title = "Patient Safety and Extended Release/Long-Acting Opioids [CME\}",

abstract = " Discusses the FDA's Risk Evaluation and Mitigation Strategy (REMS) for extended-release and long-acting (ER/LA) opioid analgesics.",

author = "Galluzzi, \{Katherine E.\}",

year = "2012",

language = "American English",

type = "Other",

}

TY - GEN

T1 - Patient Safety and Extended Release/Long-Acting Opioids [CME}

AU - Galluzzi, Katherine E.

PY - 2012

Y1 - 2012

N2 - Discusses the FDA's Risk Evaluation and Mitigation Strategy (REMS) for extended-release and long-acting (ER/LA) opioid analgesics.

AB - Discusses the FDA's Risk Evaluation and Mitigation Strategy (REMS) for extended-release and long-acting (ER/LA) opioid analgesics.

UR - http://www.medscape.org/sites/advances/long-acting-opioids

M3 - Other contribution

ER -